Intranasal buserelin versus surgery in the treatment of uterine leiomyomata: long-term follow-up
- 1 January 1991
- journal article
- clinical trial
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 38 (1) , 53-57
- https://doi.org/10.1016/0028-2243(91)90207-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Long‐term follow‐up of patients with uterine fibroids after treatment with the LHRH agonist buserelinBJOG: An International Journal of Obstetrics and Gynaecology, 1989
- Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: Assessment by magnetic resonance imagingAmerican Journal of Obstetrics and Gynecology, 1988
- A randomized, double-blind trial of a gonadotropin releasing-hormone agonist (leuprolide) with or without medroxyprogesterone acetate in the treatment of leiomyomata uteriFertility and Sterility, 1988
- Shrinkage of uterine fibroids during therapy with goserelin (Zoladex ): a luteinizing hormone-releasing hormone agonist administered as a monthly subcutaneous depotFertility and Sterility, 1987
- Toward Removing Uterine Fibroids without Surgery: Subcutaneous Infusion of a Luteinizing Hormone-Releasing Hormone Agonist Commencing in the Luteal PhaseJournal of Clinical Endocrinology & Metabolism, 1986
- Long-acting gonadotropin hormone-releasing hormone analogused to treat uteriFertility and Sterility, 1986
- Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: A pilot studyAmerican Journal of Obstetrics and Gynecology, 1985
- Uterine leiomyomata: etiology, symptomatology, and managementFertility and Sterility, 1981